EP1871752 - AMIDOPROPOXYPHENYL OREXIN RECEPTOR ANTAGONISTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 23.07.2010 Database last updated on 31.08.2024 | Most recent event Tooltip | 23.07.2010 | Application deemed to be withdrawn | published on 25.08.2010 [2010/34] | Applicant(s) | For all designated states Merck Sharp & Dohme Corp. 126 East Lincoln Avenue Rahway, NJ 07065 / US | [2010/10] |
Former [2008/01] | For all designated states Merck & Co., Inc. 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US | Inventor(s) | 01 /
COLEMAN, Paul, J. 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US | 02 /
SCHREIER, John 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 / US | [2008/01] | Representative(s) | Buchan, Gavin MacNicol, et al Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | [N/P] |
Former [2008/01] | Buchan, Gavin MacNicol, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB | Application number, filing date | 06740787.4 | 10.04.2006 | [2008/01] | WO2006US13253 | Priority number, date | US20050670542P | 12.04.2005 Original published format: US 670542 P | US20050718340P | 19.09.2005 Original published format: US 718340 P | [2008/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2006110626 | Date: | 19.10.2006 | Language: | EN | [2006/42] | Type: | A1 Application with search report | No.: | EP1871752 | Date: | 02.01.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.10.2006 takes the place of the publication of the European patent application. | [2008/01] | Search report(s) | International search report - published on: | US | 19.10.2006 | (Supplementary) European search report - dispatched on: | EP | 27.08.2009 | Classification | IPC: | C07D277/56, C07C233/69, C07C235/42, C07C237/38, C07D231/12, C07D231/14, C07D249/06, A61K31/426, A61P25/20 | [2009/40] | CPC: |
C07C237/38 (EP,US);
A61P1/04 (EP);
A61P1/08 (EP);
A61P11/06 (EP);
A61P13/02 (EP);
A61P13/08 (EP);
A61P13/12 (EP);
A61P15/00 (EP);
A61P15/10 (EP);
A61P19/10 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/20 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P3/04 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
A61P5/38 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
A61P9/04 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07C233/69 (EP,US);
C07C235/42 (EP,US);
C07D207/337 (EP,US);
C07D231/12 (EP,US);
C07D231/14 (EP,US);
C07D233/54 (EP,US);
C07D249/06 (EP,US);
C07D249/08 (EP,US);
C07D257/04 (EP,US);
C07D261/18 (EP,US);
C07D263/34 (EP,US);
C07D277/56 (EP,US);
C07D285/06 (EP,US);
C07D333/24 (EP,US);
C07D333/60 (EP,US);
|
Former IPC [2008/01] | C07D277/56 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/01] | Extension states | AL | Not yet paid | BA | Not yet paid | HR | Not yet paid | MK | Not yet paid | YU | Not yet paid | Title | German: | ANTAGONISTEN DES AMIDOPROPOXYPHENYLOREXINREZEPTORS | [2008/01] | English: | AMIDOPROPOXYPHENYL OREXIN RECEPTOR ANTAGONISTS | [2008/01] | French: | ANTAGONISTES DU RÉCEPTEUR DE L' OREXINE DE TYPE AMIDOPROPOXYPHÉNYLE | [2008/01] | Entry into regional phase | 12.11.2007 | National basic fee paid | 12.11.2007 | Search fee paid | 12.11.2007 | Designation fee(s) paid | 12.11.2007 | Examination fee paid | Examination procedure | 11.10.2007 | Amendment by applicant (claims and/or description) | 12.11.2007 | Examination requested [2008/01] | 22.10.2009 | Despatch of a communication from the examining division (Time limit: M04) | 03.03.2010 | Application deemed to be withdrawn, date of legal effect [2010/34] | 08.04.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2010/34] | Fees paid | Renewal fee | 18.03.2008 | Renewal fee patent year 03 | 16.04.2009 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 30.04.2010 | 05   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]EP1716851 (ISHIHARA SANGYO KAISHA [JP]) [E] 1-3,13,15,17,19,22 * page 18, line 9 * * page 19, line 39 * * page 22, line 19 - line 22 * * page 22, line 26 - line 27 * * page 23, line 46 - page 24, line 6 * * page 24, line 50 * * paragraph [0043] *; | [X]US5356865 (MUELLER KLAUS-HELMUT [DE], et al) [X] 1,2,13,19,20 * examples 108-111,170 *; | [X]US4649146 (TAKAYA TAKAO [JP], et al) [X] 1,3,6,13,15,17,22 * example 94 *; | [X]US3228950 (RENK ERNST F, et al) [X] 1-3,13,15,17,19 * column 6, line 43 - line 44 *; | [X]US4309433 (HIRAI KENTARO, et al) [X] 1,3,10,13,15,17,22 * claims 3-6 *; | [X] - MALAN S F ET AL, "Fluorescent ligands for the histamine H2 receptor: synthesis and preliminary characterization", BIOORGANIC & MEDICINAL CHEMISTRY, ELSEVIER SCIENCE LTD, GB, (20041215), vol. 12, no. 24, ISSN 0968-0896, pages 6495 - 6503, XP004646490 [X] 1,3,4,10,13,15,17,22 * compound 12 * DOI: http://dx.doi.org/10.1016/j.bmc.2004.09.018 | International search | [A]US4826990 (MUSSER JOHN H [US], et al) |